Showing results (21-30 of 110) with videos related to
Sort By:
Pageof 11
AIDS Research and Human Retroviruses|June 1, 1994
Transitory expansion of a CD3+TcR gamma/delta+CD16+ lymphocytic population in two patients with advanced human immunodeficiency virus infection and high levels of natural killer activityG Tambussi, V Albarello, A Gori, et al.Journal of Biological Regulators and Homeostatic Agents|August 5, 1998
Prevalence of mutation associated to resistance with nucleoside analogues in a cohort of naïve HIV-1 positive subjects during the period 1984-1997G Tambussi, E Boeri, P Carrera, et al.La Ricerca in Clinica E in Laboratorio|January 1, 1989
Partial inefficiency of T cell receptors gamma/delta composed of a heavy (55-kD) gamma chain to mediate cell activation upon binding to specific monoclonal antibodiesM C Mingari, G Tambussi, C Bottino, et al.International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement|January 1, 1989
Human thymocytes expressing gamma/delta T-cell receptorsM C Mingari, P Varese, C Bottino, et al.Anticancer Research|July 1, 1996
Cell activation and death (apoptosis) induced by IL-2: ultrastructural evidenceE Capelli, S Barni, R Vaccarone, et al.Computer Methods and Programs in Biomedicine|October 1, 2013
Identification and experimental validation of an HIV model for HAART treated patientsG Pannocchia, E Morano, M Laurino, et al.International Journal of Cancer|October 15, 1989
CD16 surface molecules regulate the cytolytic function of CD3CD16+ human natural killer cellsA Moretta, G Tambussi, E Ciccone, et al.British Journal of Cancer|November 1, 1990
LAK1 antigen defines two distinct subsets among human tumour infiltrating lymphocytesM Ferrarini, E Ferrero, C Fortis, et al.Veterinary and Comparative Oncology|January 13, 2012
Use of CD9 and CD61 for the characterization of AML-M7 by flow cytometry in a dog*F Valentini, S Tasca, A Gavazza, et al.Cancer Immunology, Immunotherapy : CII|September 1, 1994
Reversible anergy in circulating lymphocytes of cancer patients during interleukin-2 therapyE Clementi, E Bucci, G Citterio, et al.Pageof 11